Rifampicin pre-treatment inhibits the toxicity of rotenone-induced PC12 cells by enhancing sumoylation modification of α-synuclein

Daowei Lin(Sun Yat-sen University), Enxiang Tao(Sun Yat-sen University), Xiangfeng Jing(Ministry of Agriculture), Yang Chen(Sun Yat-sen Memorial Hospital), Teng Zhou(Sun Yat-sen University), Yuxia Liang(Sun Yat-sen Memorial Hospital), Jun Liu(Sun Yat-sen Memorial Hospital), Songhua Xiao(Sun Yat-sen University), Xia Wu(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Ming Lei(Shanghai University of Traditional Chinese Medicine), Sheng Peng(Sun Yat-sen Memorial Hospital), Dali Zheng(Fujian Medical University), Lianhong Yang(Sun Yat-sen University), Zhaozhao Zeng(Sun Yat-sen University)
Biochemical and Biophysical Research Communications
January 26, 2017
10.1016/j.bbrc.2017.01.100
Cited by 22

Related Papers

Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease
|Drug Delivery|2018|257
Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability
|Biomaterials|2016|173
Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
|Brain Research|2011|90
E3 Ubiquitin Ligase Cbl-b Suppresses Proallergic T Cell Development and Allergic Airway Inflammation
|Cell Reports|2014|69
Evaluating team-based, lecture-based, and hybrid learning methods for neurology clerkship in China: a method-comparison study
|BMC Medical Education|2014|64